Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-05-064946
Filing Date
2005-03-30
Accepted
2005-03-30 15:14:30
Documents
9
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2004 d10k.htm 10-K 907501
2 CERTIFICATE OF AMENDMENT TO THE ARTICLES OF INCORPORATION OF THE COMPANY dex31.htm EX-3.1 6319
3 ARTICLES OF MERGER FILED ON DECEMBER 29, 2004 dex32.htm EX-3.2 29927
4 LIST OF SUBSIDIARIES dex21.htm EX-21 1591
5 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 1889
6 SECTION 302 CEO CERTIFICATION OF BRADLEY J CARVER dex311.htm EX-31.1 7270
7 SECTION 302 CFO CERTIFICATION OF JOHN W. BURNS dex312.htm EX-31.2 7541
8 SECTION 906 CERTIFICATIONS OF BRADLEY J CARVER AND JOHN W. BURNS dex321.htm EX-32.1 4606
9 GRAPHIC g11098g57v08.jpg GRAPHIC 92781
  Complete submission text file 0001193125-05-064946.txt   1062425
Mailing Address 31 ST JAMES AVE 8TH FL BOSTON MA 02116
Business Address 31 ST. JAMES AVENUE 8TH FLOOR BOSTON MA 02116 6174220674
GLYCOGENESYS INC (Filer) CIK: 0000946661 (see all company filings)

EIN.: 330231238 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26476 | Film No.: 05713887
SIC: 2836 Biological Products, (No Diagnostic Substances)